Table 2.
Polysaccharide | Prilling Configuration | Ionic Cross-Linking Conditions | Drying Method |
Type of Particle/ Inner Structure |
Pharmaceutical Application | References |
---|---|---|---|---|---|---|
Alginate | Basic Apparatus | Inverse gelation Ca2+ |
None | Soft alginate capsules | Topical administration | [199] |
Alginate | Coaxial system | Inverse gelation Ca2+ |
None | Hydrated core-shell beads loaded with hydrophobic substances | Microencapsulation of hydrophobic compounds into a hydrophilic matrix | [200] |
Alginate | Basic Apparatus | External gelation Ca2+, Zn2+, Ca2+ plus Zn2+ |
Conventional | Only core Xerogels |
Delayed DDS for oral administration | [23,29,201,202,203] |
Alginate | Basic Apparatus | External gelation Ca2+ |
Dielectric | Only core Xerogels |
Controlled DDS for oral administration | [181,182] |
Pectin | Basic Apparatus | External gelation Zn2+ |
Conventional | Only core Xerogels |
Delayed DDS for oral administration | [204] |
Pectin | Basic Apparatus plus enteric coating ES100 | External gelation Zn2+ |
Conventional | Core/shell beads Xerogels |
Colon targeted DDS for oral administration | [32,205] |
Pectin and Alginate | Coaxial system | External gelation Zn2+ |
Conventional | Core/shell beads Xerogels |
Colon targeted DDS for oral administration | [31,43] |
Alginate, Pectin and HPMC | Basic Apparatus | External gelation: Zn2+ | Conventional | Floating Hollow Beads |
Floating and sustained release DDS for oral administration | [206] |
Alginate | Basic Apparatus | (a) External gelation Zn2+ (b) Internal gelation Ca2+ |
Conventional | Floating Hollow Beads |
Floating and sustained release DDS for oral administration | [207] |
Alginate | Basic Apparatus | External gelation Ca2+ |
Supercritical-CO2 | Only core Aerogels |
Immediate release DDS for oral administration | [208,209] |
Alginate and Pectin | Coaxial system | External gelation Ca2+ |
Supercritical-CO2 | Core/shell Aerogels |
Topical application (Wound Healing) | [44] |
Alginate | Basic Apparatus | External gelation Ca2+ |
|
|
Controlled DDS for oral administration or topical application | [169] |